Delivery Order SPE2DR25D1100-SPE2DR26FCL7K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,558.60 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,687.51 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,783.59 on November 12, 2025, for the supply of Veozah 45 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 13, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $16,639.53. This firm fixed-price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Veozah 45 mg tablets in a 30-count package. This is a firm fixed-price delivery order with a ceiling value of $1,064.69, with an ultimate completion date of October 29, 2025. The contract was not set-aside and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance, leveraging its position as a major...
- The Defense Logistics Agency awarded a delivery order valued at $16,183.30 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units). The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, under firm fixed price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,994.88 on September 24, 2025, for the supply of Veozah 45 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Veozah 45 mg tablets (30-count) under a firm fixed-price contract valued at $13,694.27. The award was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Veozah 45 mg tablets (30-count packages) valued at $9,335.84 under a firm fixed-price arrangement. This award represents a non-set-aside, competitively awarded contract with an ultimate completion date of December 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor,...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL7KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,066.11 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Veozah 45 mg tablets (30-unit package). This non-competitive, firm fixed-price delivery order is set to be completed by October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement to support federal medical supply needs within the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp leverages this prime contract vehicle to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal medical systems worldwide. The company maintains a strong track record of fulfilling federal pharmaceutical procurement requirements through open competition and serves as a critical vendor for the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 10/30/25 |